Pediatric Obesity: Clinical Trials

14 trials for Pediatric Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Pediatric Obesity: new trials by email Literature Review of Pediatric Obesity trials Research Report on Pediatric Obesity

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Young Adults With Early-onset Obesity Treated With Semaglutide
TCOC treatment, Semaglutide 3 mg/ml, Placebo (Semaglutide 3 mg/ml) - Obesity, Adolescent
Phase 4CompletedSigne Torekov2462022-05-302026-07-08
Effect of Polysaccharide-based Complex Administration on the Gut Microbiome and Cardio-Metabolic Profile in Children With Obesity and Metabolic Syndrome.
Polysaccharide-based complex - Childhood Obesity
Phase 4CompletedUniversity of Milan362022-02-012026-01-06
Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity
Metformin - Childhood Obesity, Insulin Resistance
Phase 4CompletedHÜMEYRA ACIKAN522019-11-172024-02-20
A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity
VI-0521 oral capsule, Placebo oral capsule, Lifestyle Modification - Adolescent Obesity, Obesity in Adolescence
Phase 4CompletedVIVUS LLC2232019-05-022022-09-10
Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children
Iron Supplement - Obesity, Childhood
Phase 4CompletedAin Shams University502018-10-012019-07-10
Effect of Obesity on Proton Pump Inhibitors
Lansoprazole, Pantoprazole, Midazolam - Pediatric Obesity, NAFLD
Phase 4CompletedChildren's Mercy Hospital Kansas City762018-07-032026-06-04
ZIMBA: Clinical Trial in Paediatric Obesity
Zinc, Placebos, Myoinositol - Obesity, Childhood, Insulin Resistance
Phase 4CompletedAzienda Ospedaliero Universitaria Maggiore della Carita562018-02-052024-08-09
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
Vitamin E 400 UNT, Placebo oral capsule - Obesity, Adolescent, Oxidative Stress
Phase 4CompletedUniversitas Indonesia692017-09-282018-03-02
A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents
Placebo, VI-0521 Mid Dose, VI-0521 Top Dose - Pediatric Obesity, Childhood Obesity
Phase 4CompletedVIVUS LLC422016-03-012022-08-23
Use of Metformin in Treatment of Childhood Obesity
Metformin, Placebo - Pediatric Obesity
Phase 4CompletedUniversity of Colombo3392014-07-012017-01-02
BIFI-OBESE: Clinical Trial in Paediatric Obesity
Bifidobacterium breve BR03 and Bifidobacterium breve B632, Placebos - Obesity, Childhood
Phase 4CompletedAzienda Ospedaliero Universitaria Maggiore della Carita1002013-11-202018-01-11
Evaluation of a Commercial Gaming Impact in a Childhood Obesity Intervention
weight managment program, Active Gaming - Childhood Obesity
Phase 4CompletedUnitedHealth Group772011-08-012012-12-31
A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight Youth
Aerobic Exercise Training - Type 2 Diabetes Mellitus, Adolescent Obesity
Phase 4CompletedUniversity of Manitoba1202008-04-012013-03-29
Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance
Metformin, Placebo - Pediatric Obesity, Insulin Resistance
Phase 4CompletedYale University282004-03-012009-02-18

Narrower conditions

Insulin Resistance (4)  ·  Obesity (4)  ·  Weight Loss (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fatty Liver (1)  ·  Gastroesophageal Reflux (1)  ·  Hyperinsulinism (1)  ·  Metabolic Syndrome (1)  ·  Motor Activity (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Body Weight (14)  ·  Nutrition Disorders (14)  ·  Nutritional and Metabolic Diseases (14)  ·  Overnutrition (14)  ·  Overweight (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Signs and Symptoms (14)  ·  Obesity (10)  ·  Glucose Metabolism Disorders (5)  ·  Metabolic Diseases (5)  ·  Hyperinsulinism (4)  ·  Body Weight Changes (2)  ·  Digestive System Diseases (2)  ·  Liver Diseases (2)  ·  Behavior (1)

Interventions

Metformin (3)  ·  Qsymia (2)  ·  Exergaming (1)  ·  Inositol (1)  ·  Iron-Dextran Complex (1)  ·  Lactoferrin (1)  ·  Lansoprazole (1)  ·  Midazolam (1)  ·  Pantoprazole (1)  ·  Probiotics (1)  ·  Sugars (1)  ·  Vitamin E (1)  ·  Zinc (1)  ·  semaglutide (1)

Sponsors

Azienda Ospedaliero Universitaria Maggiore della Carita (2)  ·  VIVUS LLC (2)  ·  Ain Shams University (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  HÜMEYRA ACIKAN (1)  ·  Signe Torekov (1)  ·  UnitedHealth Group (1)  ·  Universitas Indonesia (1)  ·  University of Colombo (1)  ·  University of Manitoba (1)  ·  University of Milan (1)  ·  Yale University (1)

Countries

United States (5)  ·  Italy (3)  ·  Canada (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Indonesia (1)  ·  Sri Lanka (1)  ·  Turkey (Türkiye) (1)

Top investigators

Daniel Hsia, M.D. (1)  ·  Jens-Christian Holm, Ass. Prof, PhD (1)  ·  Jonathan M McGavock, PhD (1)  ·  Kathryn Kyler, MD, MS (1)  ·  Marian GR Abdelsayed (1)  ·  Signe S Torekov, Prof, PhD (1)  ·  Tania S Burgert, MD (1)  ·  Vithanage P Wickramasinghe, MD, PhD (1)

Results publications

PMID 15482620, PMID 17850473, PMID 18761646, PMID 24522441, PMID 24589566, PMID 25376220, PMID 25774705, PMID 30156016, PMID 31146796, PMID 33544653, PMID 34229263, PMID 36968652, PMID 40518455, PMID 41501800

NIH funding

2019 (1), K23DK115827 (1)